Excretion of noradrenaline, adrenaline and vanilmandelic acid in patients with cerebro-vascular disorders during prenylamine treatment.
D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000652:urine*; D004837:Epinephrine / Q000652:urine*; D005260:Female; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000652:urine*; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine*; D011299:Prenylamine / Q000627:therapeutic use
D008333:Mandelic Acids; D011299:Prenylamine; D009638:Norepinephrine; D004837:Epinephrine